tiprankstipranks
Advertisement
Advertisement

VNRX Stock Latest News

VolitionRx Issues Shares to Settle Convertible Note Obligations
Company AnnouncementsVolitionRx Issues Shares to Settle Convertible Note Obligations
7d ago
8K
VNRX
VolitionRx Shareholders Approve Governance and Capital Changes
PremiumCompany Announcements
VolitionRx Shareholders Approve Governance and Capital Changes
24d ago
8K
VNRX
VolitionRx registers to sell 3.31M shares of common stock for holders
PremiumThe Fly
VolitionRx registers to sell 3.31M shares of common stock for holders
1M ago
VNRX
VolitionRx announces data on prognostic value of Nu.Q Cancer Assay
PremiumThe Fly
VolitionRx announces data on prognostic value of Nu.Q Cancer Assay
1M ago
VNRX
VolitionRx Converts Debt to Equity Through Share Issuances
PremiumCompany Announcements
VolitionRx Converts Debt to Equity Through Share Issuances
2M ago
8K
VNRX
VolitionRx resumed with a Buy at Maxim
PremiumThe FlyVolitionRx resumed with a Buy at Maxim
2M ago
VNRX
VolitionRx announces collaboration with Sysmex
Premium
The Fly
VolitionRx announces collaboration with Sysmex
2M ago
VNRX
VolitionRx files patent covering Nu.Q technology for Ebola triage
Premium
The Fly
VolitionRx files patent covering Nu.Q technology for Ebola triage
2M ago
VNRX
VolitionRx Secures Waiver on Convertible Note Covenant Breach
PremiumCompany Announcements
VolitionRx Secures Waiver on Convertible Note Covenant Breach
3M ago
8K
VNRX
VolitionRX Earnings Call Balances Breakthroughs and Risks
PremiumCompany Announcements
VolitionRX Earnings Call Balances Breakthroughs and Risks
3M ago
VNRX
Analyst Lifts VolitionRx Price Target to $24 on Under-Recognized Nu.Q Platform and Expanding Clinical Applications
PremiumRatings
Analyst Lifts VolitionRx Price Target to $24 on Under-Recognized Nu.Q Platform and Expanding Clinical Applications
3M ago
VNRX
VolitionRX Earnings Call: Breakthrough Science, Cash Burn Risk
PremiumCompany Announcements
VolitionRX Earnings Call: Breakthrough Science, Cash Burn Risk
3M ago
VNRX
VolitionRx Announces Board Streamlining as Director Departs
PremiumCompany AnnouncementsVolitionRx Announces Board Streamlining as Director Departs
3M ago
8K
VNRX
VolitionRx reports Q1 revenue $1M, consensus $409,920
Premium
The Fly
VolitionRx reports Q1 revenue $1M, consensus $409,920
3M ago
VNRX
VolitionRx submits manuscript for Nu.Q Vet cancer test in cats
Premium
The Fly
VolitionRx submits manuscript for Nu.Q Vet cancer test in cats
3M ago
VNRX
VolitionRx announces milestone in nucleosomes detection
PremiumThe Fly
VolitionRx announces milestone in nucleosomes detection
4M ago
VNRX
VolitionRx Enacts One-for-Twenty Reverse Stock Split
PremiumCompany Announcements
VolitionRx Enacts One-for-Twenty Reverse Stock Split
4M ago
8K
VNRX
Upcoming Stock Splits This Week (April 27 to May 1) – Stay Invested
PremiumMarket News
Upcoming Stock Splits This Week (April 27 to May 1) – Stay Invested
4M ago
UP
OCG
VolitionRx’s compliance plan accepted by NYSE American
PremiumThe Fly
VolitionRx’s compliance plan accepted by NYSE American
4M ago
VNRX
VolitionRx downgraded to Hold from Buy at D. Boral Capital
PremiumThe FlyVolitionRx downgraded to Hold from Buy at D. Boral Capital
4M ago
VNRX
VolitionRx Sets One-for-Twenty Reverse Stock Split
Premium
Company Announcements
VolitionRx Sets One-for-Twenty Reverse Stock Split
4M ago
8K
VNRX
VolitionRx Earnings Call: Breakthroughs Amid Funding Strain
Premium
Company Announcements
VolitionRx Earnings Call: Breakthroughs Amid Funding Strain
4M ago
VNRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >